Year |
Citation |
Score |
2018 |
Patki M, McFall T, Rosati R, Huang Y, Malysa A, Polin L, Fielder A, Wilson MR, Lonardo F, Back J, Li J, Matherly LH, Bepler G, Ratnam M. Chronic p27 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Scientific Reports. 8: 16006. PMID 30375484 DOI: 10.1038/S41598-018-34475-8 |
0.639 |
|
2016 |
Rosati R, Patki M, Chari V, Dakshnamurthy S, McFall T, Saxton J, Kidder BL, Shaw PE, Ratnam M. The Amino-terminal Domain of the Androgen Receptor Co-opts ERK Docking Sites in ELK1 to Induce Sustained Gene Activation that Supports Prostate Cancer Cell Growth. The Journal of Biological Chemistry. PMID 27793987 DOI: 10.1074/Jbc.M116.745596 |
0.74 |
|
2016 |
Rosati R, Chen B, Patki M, McFall T, Ou S, Heath E, Ratnam M, Qin Z. Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease HSP90 and the Androgen Receptor Levels and Inhibit Viability in Enzalutamide Resistant C4-2 Prostate Cancer Cells. Molecular Pharmacology. PMID 27382012 DOI: 10.1124/Mol.116.103416 |
0.707 |
|
2016 |
Patki M, Huang Y, Ratnam M. Restoration of the cellular secretory milieu overrides androgen dependence of in vivo generated castration resistant prostate cancer cells overexpressing the androgen receptor. Biochemical and Biophysical Research Communications. PMID 27179779 DOI: 10.1016/J.Bbrc.2016.05.058 |
0.763 |
|
2016 |
Patki M, Huang Y, Ratnam M. Abstract LB-256: Clonogenic growth of androgen receptor-overexpressing models of castration recurrent prostate cancer cells becomes insensitive to receptor ligands when their complete cellular secretory milieu is restored Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-256 |
0.671 |
|
2016 |
Rosati R, Patki M, Dakshnamurthy S, Chari V, McFall T, Ratnam M. Abstract 2876: The androgen receptor utilizes protein kinase docking sites to constitutively activate Elk1 Cancer Research. 76: 2876-2876. DOI: 10.1158/1538-7445.Am2016-2876 |
0.582 |
|
2016 |
Patki M, Huang Y, Wilson M, Fielder A, Matherly L, Polin L, Ratnam M. Long-term treatment with dexamethasone induces senescence and progressive loss of proliferation potential in lung adenocarcinoma cells expressing high levels of the glucocorticoid receptor Journal of Thoracic Oncology. 11: S36. DOI: 10.1016/J.Jtho.2015.12.061 |
0.407 |
|
2015 |
McFall T, Patki M, Rosati R, Ratnam M. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges. Oncotarget. 6: 33146-64. PMID 26356672 DOI: 10.18632/Oncotarget.5082 |
0.671 |
|
2015 |
Patki M, Salazar Md, Trumbly R, Ratnam M. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells. Biochemical and Biophysical Research Communications. 457: 404-11. PMID 25582774 DOI: 10.1016/J.Bbrc.2015.01.004 |
0.664 |
|
2015 |
McFall T, Patki M, Rosati R, Ratnam M. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges Oncotarget. 6: 33146-33164. DOI: 10.18632/oncotarget.5082 |
0.656 |
|
2015 |
McFall TB, Patki M, Rosati R, Ratnam M. Abstract 5038: Role of the short isoform of the progesterone receptor in hormone-regulated invasiveness of breast cancer cells at pre- and post-menopausal levels of estrogen and progesterone Cancer Research. 75: 5038-5038. DOI: 10.1158/1538-7445.Am2015-5038 |
0.483 |
|
2015 |
Rosati R, Chari V, Patki M, Ratnam M. Abstract 1855: Structural requirements for the association of the ETS domain transcription factor Elk1 and the androgen receptor in enabling the growth of prostate cancer cells Cancer Research. 75: 1855-1855. DOI: 10.1158/1538-7445.Am2015-1855 |
0.642 |
|
2015 |
Patki M, D'Alincourt Salazar M, Trumbly R, Ratnam M. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells Biochemical and Biophysical Research Communications. 457: 404-411. DOI: 10.1016/j.bbrc.2015.01.004 |
0.664 |
|
2014 |
Patki M, Gadgeel S, Huang Y, McFall T, Shields AF, Matherly LH, Bepler G, Ratnam M. Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 519-526. PMID 24736075 DOI: 10.1097/Jto.0000000000000111 |
0.653 |
|
2014 |
Rosati R, Patki M, Chari V, Ratnam M. Abstract 2116: Mapping peptides critical for association of the androgen receptor with Elk1 Cancer Research. 74: 2116-2116. DOI: 10.1158/1538-7445.Am2014-2116 |
0.63 |
|
2014 |
Patki M, Salazar Md, Trumbly R, Ratnam M. Abstract 2111: Role of gene repression by estrogen in invasiveness of breast cancer cells Cancer Research. 74: 2111-2111. DOI: 10.1158/1538-7445.Am2014-2111 |
0.5 |
|
2013 |
Patki M, Chari V, Sivakumaran S, Gonit M, Trumbly R, Ratnam M. The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells Journal of Biological Chemistry. 288: 11047-11065. PMID 23426362 DOI: 10.1074/Jbc.M112.438473 |
0.549 |
|
2013 |
Ratnam M, Patki M, Gonit M, Trumbly R. Mechanisms of ARE-independent gene activation by the androgen receptor in prostate cancer cells: Potential targets for better intervention strategies Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 2147483647: 85-100. DOI: 10.1007/978-1-4614-6182-1_6 |
0.739 |
|
2011 |
Salazar MD, Ratnam M, Patki M, Kisovic I, Trumbly R, Iman M. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein Breast Cancer Research. 13. PMID 21299862 DOI: 10.1186/Bcr2827 |
0.662 |
|
2011 |
Sivakumaran S, Gonit M, Patki M, Trumbly R, Ratnam M. Abstract B12: The androgen receptor is a critical coactivator of Elk1 in prostate cancer cells Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-B12 |
0.69 |
|
Show low-probability matches. |